Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
bluebird bio (BLUE)
NASDAQ:BLUE
Bluebird Bio (BLUE) Stock Price & Analysis
2,088 Followers
BLUE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.87 - $8.58
Previous Close$6.35
Volume2.90M
Average Volume (3M)3.77M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$139.63M
Total Debt (Recent Filing)$278.21M
Price to Earnings (P/E)-1.0
Beta0.18
Next EarningsFeb 22, 2023
EPS Estimate-$0.43
Last Dividend Ex-DateNov 05, 2021
Dividend YieldN/A
1Y Price Target$6.67
EPS (TTM)-6.09
Shares Outstanding82,923,298
R-Squared0.10
Standard Deviation0.17
10 Day Avg. Volume5,439,801
30 Day Avg. Volume3,766,086
Price to Book (P/B)3.20
Price to Sales (P/S)145.48
Price to Cash Flow (P/CF)5.70
P/FCF Ratio-1.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside4.55% Upside
Rating ConsensusHold
Alpha-0.04
Number of Analyst Covering4
Bluebird Bio News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLUE FAQ
What was Bluebird Bio’s price range in the past 12 months?
Bluebird Bio lowest stock price was $2.87 and its highest was $8.58 in the past 12 months.
What is Bluebird Bio’s market cap?
Currently, no data Available
When is Bluebird Bio’s upcoming earnings report date?
Bluebird Bio’s upcoming earnings report date is Feb 22, 2023 which is in 20 days.
How were Bluebird Bio’s earnings last quarter?
Bluebird Bio released its earnings results on Nov 07, 2022. The company reported -$0.94 earnings per share for the quarter, beating the consensus estimate of -$1.117 by $0.177.
Is Bluebird Bio overvalued?
According to Wall Street analysts Bluebird Bio’s price is currently Undervalued.
Does Bluebird Bio pay dividends?
Bluebird Bio pays a Notavailable dividend of $8.88 which represents an annual dividend yield of N/A. See more information on Bluebird Bio dividends here
What is Bluebird Bio’s EPS estimate?
Bluebird Bio’s EPS estimate is -$0.43.
How many shares outstanding does Bluebird Bio have?
Bluebird Bio has 102,923,300 shares outstanding.
What happened to Bluebird Bio’s price movement after its last earnings report?
Bluebird Bio reported an EPS of -$0.94 in its last earnings report, beating expectations of -$1.117. Following the earnings report the stock price went up 11.093%.
Which hedge fund is a major shareholder of Bluebird Bio?
Among the largest hedge funds holding Bluebird Bio’s share is Woodline Partners LP. It holds Bluebird Bio’s shares valued at 7M.
---
Bluebird Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$6.67
$6.67
Blogger Sentiment
Bullish
BLUE Sentiment 88%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 659.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $72.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-18.85%
12-Months-Change
Fundamentals
Return on Equity
-83.77%
Trailing 12-Months
Asset Growth
-61.18%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
bluebird bio
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.
---
---